Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

BLANCA R VAZQUEZ

Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology

NPI
1255449716
CMS profile
56645
Location
NEW YORK, NY

General Payments · PY2018–2024

$31,649.30

  • Reported across 77 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$11,061.14

13 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Neurelis, Inc. $7,372.65 7
UCB, Inc. $3,364.15 2
CATALYST PHARMACEUTICALS, INC. $113.28 1
SK Life Science, Inc. $111.42 1
LivaNova USA, Inc. $80.84 1
ABBVIE INC. $18.80 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $2,774.71 4
PY2019 $558.53 17
PY2020 $15,731.43 21
PY2021 $868.25 3
PY2022 $323.62 5
PY2023 $331.62 14
PY2024 $11,061.14 13

Payment records · PY2024 (13)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $18.80 08/12/2024 Food and Beverage Undisputed 01/23/2026 1106275602 CMS
CATALYST PHARMACEUTICALS, INC. $113.28 03/20/2024 Food and Beverage Undisputed 01/23/2026 1144457629 CMS
LivaNova USA, Inc. $80.84 05/16/2024 Food and Beverage Undisputed 01/23/2026 1152787821 CMS
Neurelis, Inc. $506.00 08/22/2024 Consulting Fee Undisputed 01/23/2026 1145657687 CMS
Neurelis, Inc. $1,069.60 10/30/2024 Travel and Lodging Undisputed 01/23/2026 1145657690 CMS
Neurelis, Inc. $553.89 11/01/2024 Travel and Lodging Undisputed 01/23/2026 1145657692 CMS
Neurelis, Inc. $33.16 11/09/2024 Food and Beverage Undisputed 01/23/2026 1145657694 CMS
Neurelis, Inc. $3,036.00 11/21/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1145657696 CMS
Neurelis, Inc. $150.00 11/25/2024 Food and Beverage Undisputed 01/23/2026 1145657698 CMS
Neurelis, Inc. $2,024.00 12/05/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1145657701 CMS
SK Life Science, Inc. $111.42 05/08/2024 Food and Beverage Undisputed 01/23/2026 1154111317 CMS
UCB, Inc. $3,360.00 01/29/2024 Consulting Fee Undisputed 01/23/2026 1143258464 CMS
UCB, Inc. $4.15 02/21/2024 Food and Beverage Undisputed 01/23/2026 1143258469 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.